Central Nervous System - Study No 1

Multiple Sclerosis

• International, phase III, placebo-controlled study in patients with relapsing-remitting multiple sclerosis with competitive screening
• Planned target of 80 patients randomized achieved within 3,5 months
• 8 sites participating
• Recruitment finished with 133 patients (145% of goal) done in 5 months